Immunometabolism (Cobham, Surrey)

Brain metabolism changes in chronic fatigue syndrome and Long COVID

Updated

Abstract

Essence

Metabolic neuroimaging suggests ME/CFS and Long-COVID may share brain energy-metabolism and neuroinflammatory disruptions.

Evidence

This mini review summarizes PET and MRI/MRS studies reporting changes in glucose and oxygen metabolism, neurotransmitter balance, and oxidative stress in ME/CFS and Long-COVID.

Caveat

Metabolite findings are inconsistent across conditions and need standardized definitions, stratified samples, and longitudinal validation.

Simplified

Key figures

Figure 1.
Hypothesized disease progression and metabolic changes in from early inflammation to dysfunction
Frames a progression from early inflammation to metabolic failure and dysfunction in ME/CFS disease stages
in9-7-e00068-g001
  • Entire diagram
    Shows initial responses to predisposing factors leading to inflammation, immune and central nervous system responses, oxidative and , cell dysfunction, and systemic metabolic failure progressing to
  • Left side
    Disease stages from prodromal period through early to established disease aligned with increasing irreversibility
  • Center top
    Anti-inflammatory response and hyperinflammation linked to immune system and central nervous system responses
  • Center bottom
    , nitrosamine stress, , , and shown in a cycle of cell dysfunction
  • Right center
    Systemic hypermetabolic state leading to metabolic failure and 'power saving mode' factors or insults
  • Right side
    Neuro-endocrine, autonomic, and circulatory dysfunctions contributing to homeostatic dysfunction
Figure 2.
Hypothesized biological processes linking acute to symptoms
Frames a complex network of immune and tissue dysfunction processes potentially sustaining Long-COVID symptoms
in9-7-e00068-g002
  • Single panel
    Flowchart shows SARS-CoV-2 infection triggering , direct viral tissue invasion, and subsequent immune and tissue dysfunction pathways leading to Long-COVID
Figure 3.
syndrome patients vs control patients: brain glucose metabolism patterns and pattern expression scores
Frames a clear contrast in brain glucose metabolism patterns and shows similar pattern expression scores in Long COVID and controls
in9-7-e00068-g003
  • Panel A
    Group averaged and spatially normalized scans of Long COVID syndrome patients (n = 14) showing brain glucose metabolism at multiple axial slices (z = -25 to 50)
  • Panel B
    Group averaged and spatially normalized FDG-PET scans of healthy control patients (n = 45) at the same axial slices as Panel A
  • Panel C
    Boxplot of pattern expression scores () of COVID-19-related pattern comparing Long COVID syndrome patients and control patients, showing no significant difference
Figure 4.
placement and average magnetic resonance spectroscopy spectrum in healthy controls
Anchors metabolic brain imaging by showing precise voxel location and typical spectral profile in healthy controls
in9-7-e00068-g004
  • Panel left
    Voxel placement in the on an scan
  • Panel right
    Average spectrum from 10 healthy controls showing metabolite peaks across frequencies ()
1 / 4

Full Text

What this is

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID are complex conditions with overlapping symptoms and significant public health implications.
  • Neuroimaging techniques like PET and MRI have revealed metabolic abnormalities in these disorders, particularly in glucose and oxygen metabolism.
  • This review summarizes current findings, highlights similarities and differences between ME/CFS and Long-COVID, and identifies gaps in knowledge that require further research.

Essence

  • Metabolic neuroimaging reveals shared features of and elevated in ME/CFS and Long-COVID, while distinct differences in oxygen extraction and lactate levels suggest differing underlying mechanisms.

Key takeaways

  • Both ME/CFS and Long-COVID exhibit , particularly in brain regions linked to cognitive function and fatigue. This suggests a common metabolic dysfunction that may underlie symptoms in both conditions.
  • Elevated levels have been reported in both disorders, potentially indicating neuroinflammation. However, differences in oxygen extraction rates point to distinct metabolic responses, with Long-COVID showing higher oxygen extraction compared to classic ME/CFS.
  • The review emphasizes the need for standardized diagnostic criteria and harmonized research methodologies to enhance comparability across studies, which is crucial for advancing understanding and treatment of these conditions.

Caveats

  • Inconsistencies in findings across studies highlight the complexity of ME/CFS and Long-COVID, suggesting that variations in disease severity, duration, and methodology may impact results.
  • Most studies reviewed are limited by small sample sizes and lack systematic reporting of confounding factors, which may affect the generalizability of the findings.
  • Further research is needed to explore undercharacterized metabolic pathways, including lactate and glutathione metabolism, to fully understand their roles in ME/CFS and Long-COVID.

Definitions

  • Glucose hypometabolism: Reduced glucose metabolism in the brain, which can impair cognitive and autonomic functions.
  • Glutamate: An excitatory neurotransmitter in the brain, elevated levels may indicate neuroinflammation.
  • Oxygen extraction fraction (OEF): The measure of how much oxygen is extracted from blood as it passes through the brain, indicating cerebral oxygen utilization.

Simplified

Funding

Competing interests

0 of 6
authors report competing interests
6 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free